Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
9.05
0.10 (1.12%)
At close: Aug 15, 2025, 3:59 PM
9.24
2.10%
After-hours: Aug 15, 2025, 07:50 PM EDT
Avalo Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 42.31M | 125.05M | 134.55M | 81.86M | 93.43M | 110.18M | 7.42M | 10.18M | 6.31M | 16.69M | 13.17M | 16.94M | 11.25M | 38.47M | 54.59M | 71.51M | 40.44M | 38.29M |
Short-Term Investments | 70.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 210K | n/a | n/a | n/a | 131K | 131K | 131K | 131K | 131K | 131K | 131K | 181K | 227K | 227K | 227K | 227K | 149K | 149K |
Other Long-Term Assets | n/a | 131K | 131K | 131K | 131K | 131K | 131K | 131K | 131K | 131K | 131K | 181K | n/a | 1M | 1M | 2M | n/a | n/a |
Receivables | n/a | n/a | 611K | 998K | 33K | 35K | 136K | 1.54M | 44K | 857K | 1.92M | 1.31M | 1.85M | 2.38M | 4.8M | 3.91M | 5.12M | 5.19M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 18K | 19K | 20K | 22K | 23K | 25K | 38K | 16K | 20K | 153K |
Other Current Assets | 1.9M | 1.9M | 3.73M | 3.29M | 2.44M | 1M | 844K | 941K | 1.15M | 1.69M | 1.3M | 53K | 14K | 100K | 51K | 164K | 41K | 153K |
Total Current Assets | 115.19M | 126.94M | 138.89M | 86.15M | 95.89M | 111.21M | 8.39M | 12.66M | 7.52M | 19.25M | 16.42M | 19.45M | 15.02M | 43.66M | 61.84M | 77.01M | 47.36M | 46.1M |
Property-Plant & Equipment | 686K | 949K | 1.21M | 1.67M | 1.78M | 1.88M | 1.97M | 2.07M | 2.18M | 2.44M | 2.41M | 2.51M | 2.57M | 2.6M | 2.69M | 1.41M | 1.43M | 1.53M |
Goodwill & Intangibles | 10.5M | 10.5M | 10.5M | 10.5M | 10.5M | 10.5M | 10.5M | 14.41M | 14.41M | 14.41M | 14.41M | 14.41M | 14.41M | 14.41M | 14.45M | 14.71M | 15.14M | 15.57M |
Total Long-Term Assets | 11.4M | 11.58M | 11.84M | 12.31M | 12.41M | 12.52M | 12.6M | 16.61M | 16.72M | 16.98M | 16.95M | 17.1M | 17.2M | 18.24M | 18.37M | 18.35M | 16.72M | 17.25M |
Total Assets | 126.58M | 138.52M | 150.73M | 98.45M | 108.31M | 123.73M | 20.99M | 29.27M | 24.23M | 36.23M | 33.37M | 36.55M | 32.22M | 61.9M | 80.21M | 95.36M | 64.08M | 63.34M |
Account Payables | 2.37M | 681K | 283K | 1.81M | 654K | 916K | 446K | 789K | 751K | 5.57M | 2.88M | 1.45M | 2.16M | 3.76M | 3.37M | 3.57M | 3.96M | 11.91M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -536K | -535K | 111K | 88K | 442K | 12.7M | n/a | 16.02M | 15.23M | 17.32M | 13.86M |
Short-Term Debt | 482K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.12M | 9.3M | 5.93M | 2.56M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 4.27M | 2.13M | 3.24M | 58.07M | 91.47M | 211.22M | 1.87M | 2.16M | 1.86M | 5.61M | 9.98M | 10.2M | 1.77M | 1.91M | 1.74M | 2.01M | 2.55M | 3.86M |
Total Current Liabilities | 9.26M | 5.62M | 6.96M | 60.67M | 96.4M | 215.7M | 4.62M | 6M | 22.45M | 23.25M | 22.11M | 18.15M | 15.39M | 17.89M | 19.89M | 19.04M | 21.67M | 26.36M |
Long-Term Debt | 2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.47M | 13.49M | 16.5M | 18.71M | 33.18M | 32.83M | 32.48M | 17.14M | n/a |
Other Long-Term Liabilities | 10.26M | 9.74M | 10.47M | 16.55M | 13.89M | 8.95M | 8.92M | 8.41M | 8.59M | 8.64M | 8.54M | 3.79M | 3.94M | 4.36M | 4.3M | 3.4M | 3.56M | 3.72M |
Total Long-Term Liabilities | 12.75M | 10.29M | 10.74M | 16.7M | 14.06M | 9.11M | 9.07M | 8.57M | 8.75M | 19.26M | 22.17M | 20.43M | 22.78M | 37.66M | 37.24M | 36.01M | 20.82M | 3.83M |
Total Liabilities | 22.01M | 15.91M | 17.7M | 77.38M | 110.46M | 224.81M | 13.69M | 14.57M | 31.2M | 42.5M | 44.28M | 38.58M | 38.17M | 55.56M | 57.13M | 55.05M | 42.5M | 30.19M |
Total Debt | 2.68M | 801K | 568K | 550K | 1.73M | 1.83M | 3.9M | 536K | 14.65M | 19.77M | 19.95M | 19.07M | 19.24M | 33.7M | 32.83M | 32.7M | 17.43M | 357K |
Common Stock | 11K | 11K | 10K | 10K | 1K | 1K | 1K | 192K | 14K | 13K | 9K | 9K | 9K | 113K | 113K | 112K | 96K | 89K |
Retained Earnings | -404.18M | -383.41M | -370.26M | -334.92M | -357.96M | -456.42M | -335.13M | -326.97M | -321.74M | -313.78M | -303.82M | -294.01M | -297.2M | -284.22M | -262.17M | -242.97M | -225.57M | -208.47M |
Comprehensive Income | -34K | n/a | n/a | n/a | -11.46M | -11.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | -0.00 | n/a |
Shareholders Equity | 104.57M | 122.61M | 133.03M | 21.08M | -2.15M | -101.08M | 7.3M | 14.7M | -6.97M | -6.27M | -10.91M | -2.03M | -5.95M | 6.34M | 23.08M | 40.31M | 21.59M | 33.16M |
Total Investments | 71.18M | n/a | n/a | n/a | 131K | 131K | 131K | 131K | 131K | 131K | 131K | 181K | 227K | 227K | 227K | 227K | 149K | 149K |